Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Fgfr4 Knockout Mouse Model for Respiratory System Studies
Case ID:
TAB-2403
Web Published:
12/6/2022
FGFR4 knockout: Lung alveoli fail to develop normally in double mutant with FGFR4 and FGFR3 knockouts.
The fibroblast growth factor receptor 4 (
fgfr-4
) gene was inactivated by targeted disruption and homozygous recombination to study its possible role in lung development. FGFR-4 is expressed in postnatal lung, and FGFR-4 null mice have no obvious abnormalities. However, mice that are doubly homozygous for targeted disruptions of FGFR3 and FGFR4 display novel phenotypes, including pronounced dwarfism and lung abnormalities. The lungs of the double knockout mice are normal at birth, but they fail to develop secondary septae that delimit alveoli and increase the surface area of the lung. Although lung function is impaired, the double homozygous knockout mice are viable but sickly.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Fgfr4_Knockout_Mouse_Model_f or_Respiratory_System_Studies
Keywords:
4
factor
FGFR4
Fibroblast
Generation
Growth
IDXXXX
IXXXXX
Knockout
Mice
RECEPTOR
Bookmark this page
Download as PDF
For Information, Contact:
Inteum Admin
NIH Technology Transfer